A specific nuclear DNA background is required for high frequency lymphoma development in transmitochondrial mice with G13997A mtDNA

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Hashizume, Osamu ^a   Yamanashi, Haruka ^a   Taketo, Makoto M ^b   Nakada, Kazuto ^a   Hayashi, Jun Ichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CELL NUCLEUS DNA; GLYCINE; MITOCHONDRIAL DNA; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, MOUSE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACKCROSSING; CANCER GROWTH; CANCER SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE MUTATION; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ADENOMA; LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; SURVIVAL TIME; ADENOMA; ANIMAL; CARCINOGENESIS; CELL NUCLEUS; CHEMICALLY INDUCED; DEFICIENCY; DISEASE COURSE; GENETIC BACKGROUND; GENETICS; GENOMICS; INBREEDING; LIVER TUMOR; METABOLISM; MITOCHONDRION; PATHOLOGY;

MUS;

ADENOMA; ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; GENETIC BACKGROUND; GENOMICS; INBREEDING; LIVER NEOPLASMS; LYMPHOMA; MICE; MITOCHONDRIA; NEOPLASM METASTASIS; PROTEIN-SERINE-THREONINE KINASES; URETHANE;

EID: 84929012224     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118561     Document Type: Article

References (25)

1. Baysal BE, Ferrell RE, Willet-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000; 287: 848-851. PMID: 10657297
2. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type3. Nat Genet. 2000; 26: 268-270. PMID: 11062460
3. Gottlieb E, Tomlinson IP. Mitochondrial tumor suppressors: a genetic and biochemical update. Nat Rev Cancer. 2005; 5: 857-866. PMID: 16327764
4. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011; 11: 325-337. doi: 10.1038/nrc3038 PMID: 21508971
5. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999; 283: 1482-1488. PMID: 10066162
6. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005; 6: 389-402. PMID: 15861210
7. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, et al. Somatic mutations of the mitochondrial genome in human colorectal tumors. Nat Genet. 1998; 20: 291-293. PMID: 9806551
8. Fliss MS, Usadei H, Caballero OL, Wu L, Buta MR, Eleff SM, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000; 287: 2017-2019. PMID: 10720328
9. He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, et al. Heteroplasmic mitochondrial DNA mutations in normal and tumor cells. Nature. 2010; 464: 610-614. doi: 10.1038/ nature08802 PMID: 20200521
10. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008; 320: 661-664. doi: 10.1126/science.1156906 PMID: 18388260
11. Akimoto M, Niikura M, Ichikawa M, Yonekawa H, Nakada K, Honma Y, et al. Nuclear DNA but not mtDNA controls tumor phenotypes in mouse cells. Biochem Biophys Res Commun. 2005; 327: 1028-1035. PMID: 15652499
12. Ishikawa K, Hashizume O, Koshikawa N, Fukuda S, Nakada K, Takenaga K, et al. Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis. FEBS Lett. 2008; 582: 3525-3530. doi: 10. 1016/j.febslet.2008.09.024 PMID: 18805414
13. Yokota M, Shitara H, Hashizume O, Ishikawa K, Nakada K, Ishii R, et al. Generation of trans-mitochondrial mito-mice by the introduction of a pathogenic G13997A mtDNA from highly metastatic lung carcinoma cells. FEBS Lett. 2010; 584: 3943-3948. doi: 10.1016/j.febslet.2010.07.048 PMID: 20674568
14. Hashizume O, Shimizu A, Yokota M, Sugiyama A, Nakada K, Miyoshi H, et al. Specific mitochondrial DNA mutation in mice regulates diabetes and lymphoma development. Proc Natl Acad Sci USA. 2010; 109: 10528-10533.
15. Kasahara A, Ishikawa K, Yamaoka M, Ito M, Watanabe N, Akimoto M, et al. Generation of trans-mitochondrial mice carrying homoplasmic mtDNAs with a missense mutation in a structural gene using ES cells. Hum Mol Genet. 2006; 15: 871-881. PMID: 16449238
16. Krupke DM, Begley DA, Sundberg JP, Bult CJ, Eppig JT. The Mouse Tumor Biology database. Nat Rev Cancer. 2008; 8: 459-465. doi: 10.1038/nrc2390 PMID: 18432250
17. Miyoshi H, Nakau M, Ishikawa TO, Seldin MF, Oshima M, Taketo MM. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res. 2002; 62: 2261-2266. PMID: 11956081
18. Nakau M, Miyoshi H, Seldin MF, Imamura M, Oshima M, Taketo MM. Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res. 2002; 62: 4549-4553. PMID: 12183403
19. Manenti G, Acevedo A, Galbiati F, Gianni Barrera R, Noci S, Salido E, et al. Cancer modifier alleles inhibiting lung tumorigenesis are common in inbred mouse strains. Int J Cancer. 2002; 99: 555-559. PMID: 11992545
20. Miller YE, Dwyer-Nield LD, Keith RL, Le M, Franklin WA, Malkinson AM. Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections. Cancer Lett. 2003; 198: 139-144. PMID: 12957351
21. Balmain A, Nagase H. Cancer resistance genes in mice: models for the study of tumour modifiers. Trends Genet. 1998; 14: 139-144. PMID: 9594661
22. Harvey M, McArthur MJ, Montgomery CA Jr, Bradley A, Donehower LA. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 1993; 7: 938-943. PMID: 8344491
23. Freeman D, Lesche R, Kertesz N, Wang S, Li G, Gao J, et al. Genetic background controls tumor development in PTEN-deficient mice. Cancer Res. 2006; 66: 6492-6496. PMID: 16818619
24. Shimizu A, Mito T, Hayashi C, Ogasawara E, Koba R, Negishi I, et al. Transmitochondrial mice as models for primary prevention of disease caused by mutation in the tRNA(Lys) gene. Proc Natl Acad Sci USA. 2014; 111: 3104-3109. doi: 10.1073/pnas.1318109111 PMID: 24510903
25. Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014; 515: 431-435. doi: 10.1038/nature13909 PMID: 25383517